Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia

Leukemia. 2014 Jan;28(1):185-9. doi: 10.1038/leu.2013.191. Epub 2013 Jun 21.

Authors

C Y Ok¹, R P Hasserjian², P S Fox³, F Stingo³, Z Zuo¹, K H Young¹, K Patel¹, L J Medeiros¹, G Garcia-Manero⁴, S A Wang¹

Affiliations

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
³ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 23787392
DOI: 10.1038/leu.2013.191

No abstract available

Publication types

Letter

MeSH terms

Female
Humans
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Myelodysplastic Syndromes / pathology
Myelodysplastic Syndromes / therapy*
Prognosis